Current treatment paradigms in the management of lymphatic malformations

Laryngoscope

Volumn 121, Issue 1, 2011, Pages 56-59

  Renton, John P ^a   Smith, Richard J H ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

lymphangiogenesis; lymphatic malformations; surgery

Indexed keywords

ALCOHOL; BLEOMYCIN; DOXYCYCLINE; PICIBANIL; SCLEROSING AGENT;

ARTICLE; CHILD; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CYST; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; EXCISION; HOSPITAL READMISSION; HUMAN; IMMUNOTHERAPY; INFANT; LYMPHANGIOGENESIS; LYMPHATIC MALFORMATION; LYMPHATIC SYSTEM; LYMPHATIC SYSTEM DISEASE; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE DRUG DOSE; STREPTOCOCCUS PYOGENES; TREATMENT RESPONSE; ULTRASOUND; VASCULAR TUMOR;

CHILD; HEAD; HUMANS; LYMPHATIC ABNORMALITIES; LYMPHATIC SYSTEM; NECK; SCLEROSING SOLUTIONS; SCLEROTHERAPY;

EID: 78651096920     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20768     Document Type: Article

References (30)

1. Wiegand S, Eivazi B, Barth PJ, et al. Pathogenesis of lymphangiomas. Virchows Arch 2008; 453: 1-8.
2. Sabin FR,. The lymphatic system in human embryos with a consideration of the morphology of the system as a whole. Am J Anat 1909; 9: 43-45.
3. Jain RK, Padera TP,. Lymphatics make the break. Science 2003; 299: 209-210.
4. Huntington GS, McClure CFW,. The anatomy and development of the jugular lymph sac in the domestic cat (felis domestica). Anat Rec 1908; 2: 1-19.
5. Schneider M, Othman-Hassan K, Christ B, Wilting J,. Lymphangioblasts in the avian wing bud. Dev Dyn 1999; 216: 311-319.
6. Van der Jagt ER,. The origin and development of the anterior lymph-sacs in the sea-turtle (thalasso-chelys caretta). Q J Microsc Sci 1932; 75: 151-163.
7. Emery PJ, Bailey CM, Evans JN,. Cystic hygroma of the head and neck. A review of 37 cases. J Laryngol Otol 1984; 98: 613-619.
8. Smith RJ,. Lymphatic malformations. Lymphat Res Biol 2004; 2: 25-31.
9. Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM,. 25 years' experience with lymphangiomas in children. J Pediatr Surg 1999; 34: 1164-1168.
10. Wernher A,. Die angeborenen kysten-hygroma und die ihnen verwandten geschwulste in anatomischer, diagnostischer und therapeutischer. 1843.
11. Mulliken JB, Glowacki J,. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69: 412-422.
12. Giguere CM, Bauman NM, Sato Y, et al. Treatment of lymphangiomas with OK-432 (picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg 2002; 128: 1137-1144.
13. Paltiel HJ, Burrows PE, Kozakewich HP, Zurakowski D, Mulliken JB,. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 2000; 214: 747-754.
14. Jackson IT, Carreno R, Potparic Z, Hussain K,. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 1993; 91: 1216-1230.
15. Semelka RC, Armao DM, Elias J Jr, Huda W,. Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging 2007; 25: 900-909.
16. Cordes BM, Seidel FG, Sulek M, Giannoni CM, Friedman EM,. Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations. Otolaryngol Head Neck Surg 2007; 137: 962-964.
17. Dubois J, Garel L, Abela A, Laberge L, Yazbeck S,. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997; 204: 651-654.
18. Herbreteau D, Riche MC, Enjolras O, et al. Percutaneous embolization with ethibloc of lymphatic cystic malformations with a review of the experience in 70 patients. Int Angiol 1993; 12: 34-39.
19. Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M,. OK-432 (picibanil) therapy for lymphangiomas in children. Eur Arch Otorhinolaryngol 2002; 259: 274-278.
20. Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T,. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol 2005; 69: 75-80.
21. Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG,. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 2008; 43: 451-460.
22. Ogita S, Tsuto T, Tokiwa K, Takahashi T,. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987; 74: 690-691. (Pubitemid 17108421)
23. Sanlialp I, Karnak I, Tanyel FC, Senocak ME, Buyukpamukcu N,. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 2003; 67: 795-800.
24. Sung MW, Lee DW, Kim DY, et al. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 2001; 111: 1430-1433.
25. Tanigawa N, Shimomatsuya T, Takahashi K, et al. Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion. Cancer 1987; 60: 741-749.
26. Yura J, Hashimoto T, Tsuruga N, Shibata K,. Bleomycin treatment for cystic hygroma in children. Nippon Geka Hokan 1977; 46: 607-614.
27. Sung MW, Chang SO, Choi JH, Kim JY,. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. Am J Otolaryngol 1995; 16: 236-241.
28. Gericke KR,. Doxycycline as a sclerosing agent. Ann Pharmacother 1992; 26: 648-649.
29. Torisu M, Fujimura T, Kato M,. Successful immunotherapy of carcinomatous pleuritis and peritonitis by intracavitary injection of OK-432. Clin Exp Stud Immunother 1983: 99-112.
30. Smith MC, Zimmerman MB, Burke DK, et al. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 2009; 119 (1): 107-115.